Porównaj metody
Przeglądaj wybrane metody obok siebie; wiersze, które się różnią, są wyróżnione.
| MSFC: Multiple Sclerosis Functional Composite× | MDS-UPDRS× | |
|---|---|---|
| Dziedzina | Neurologia | Neurologia |
| Rodzina | Process / pipeline | Process / pipeline |
| Rok powstania≠ | 1999 | 2008 |
| Twórca≠ | Gary Cutter, Richard Rudick, and NMSS Consortium | Christopher G. Goetz and Movement Disorder Society |
| Typ≠ | Clinician-administered performance test | Clinician-rated |
| Źródło pierwotne≠ | Cutter, G. R., Baier, M. L., Rudick, R. A., et al. (1999). Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Multiple Sclerosis, 5(4), 244-250. DOI ↗ | Goetz, C. G., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129-2170. DOI ↗ |
| Inne nazwy | MS Functional Composite | UPDRS |
| Pokrewne≠ | 4 | 5 |
| Podsumowanie≠ | The Multiple Sclerosis Functional Composite (MSFC) is an objective, performance-based assessment of MS-related disability capturing three key functional domains: lower extremity mobility, upper extremity coordination, and cognitive/processing speed. Developed in 1999 by the National MS Society and adopted widely in clinical trials, the MSFC provides quantifiable endpoints complementing the Expanded Disability Status Scale (EDSS). The three-component design addresses EDSS limitations by including cognition and standardizing measurement via timed tasks. | The MDS-UPDRS is the gold-standard clinician-administered rating scale for assessing motor and non-motor manifestations of Parkinson's disease. Developed by the Movement Disorder Society in 2008 to enhance the original UPDRS, it measures disease severity across daily living, motor function, and treatment complications. Used globally in clinical trials, longitudinal cohort studies, and routine neurological practice. |
| ScholarGateZbiór danych ↗ |
|
|